RxDoctor Payments Data

Daniel Scher

Otolaryngology · Wayne, NJNPI 1912946583

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,216 of the $3,599 with a category attached, or 89.4%. It is spread thinly across 29 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations.

$3,599in general payments, 2019–2025

Across 167 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$669
  • Aerin Medical Inc.$508
  • Biosense Webster, Inc.$383
  • GSK$364
  • Optinose US, Inc.$289
  • Regeneron Healthcare Solutions, Inc.$277
  • plus $1K from 23 others

What the payments were for

  • Travel & lodging$38311%
  • Food & beverage$3,21689%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,599 in reported general payments places this provider in the 80th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$280,032
Medicare patients
721
Services billed
4,776

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate271$3,618
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth24$2,552
Montelukast Sodium229$2,174
Fluocinolone Acetonide Oil56$2,117
Ipratropium Bromide48$1,418
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort23$1,092
Famotidine55$845
Levothyroxine Sodium21$762
Mupirocin77$605
Azelastine Hcl20$541
Methylprednisolone81$493
Pantoprazole Sodium51$491
CefuroximeCefuroxime Axetil34$392
Ofloxacin11$203
Prednisone79$191

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Wayne

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →